Skip to main content
OpenTrials

Clinical trial condition

Triple-negative Breast Cancer

Explore clinical trials studying Triple-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

78 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Triple-negative Breast Cancer trial results

Completed

A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer

NCT03499899

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site Wooloongabba, Queensland, Australia
View all 33 locations
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

NCT02071862

Conditions
Adenocarcinoma, Adenoma, Breast Diseases, +38 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute of Emory School of Medicine Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Safety Study of MGA271 in Refractory Cancer

NCT01391143

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +49 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

NCT02413320

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Kansas Cancer Center - CRC Fairway, Kansas, United States
  • Hays Medical Center Hays, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • Salina Regional Health Center Salina, Kansas, United States
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions